J Crit Care
A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibition.
Sanusi I, Sarnowski A, Russell-Jones D, Forni LG
Sodium glucose cotransporter 2 (SGLT2) inhibitors are the latest class of oral hypoglycaemic agents approved to treat type II diabetes. Their use is i ...
Read More
Source: PubMed
Endocrinol Diabetes Nutr 2020 Jan 29
Long-term effects of continuous subcutaneous insulin infusion in adults with type 1 diabetes mellitus patients: Results of a public healthcare system.
Moreno-Fernandez J, López LM, Gomez FJ, Pinés P, Blanco B, González J, López J, Herranz S, Roa C, Gómez-Romero FJ
To evaluate the long-term clinical effect of continuous subcutaneous insulin infusion (CSII) in adult type 1 diabetes mellitus (T1DM) patients in a re ...
Read More
Source: PubMed
Nephrol. Dial. Transplant.
Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes.
van Raalte DH, Bjornstad P
Diabetic kidney disease (DKD) is a common complication of type 1 diabetes (T1D) and a major risk factor for premature death from cardiovascular diseas ...
Read More
Source: PubMed
Open Access Maced J Med Sci
Sepsis in Latent Autoimmune Diabetes in Adults with Diabetic Ketoacidosis: A Case Report.
Rahmadi A, Decroli E, Kam A
This case report intends to highlight the challenge in diagnosing type 1 diabetes on an adult patient. Latent Autoimmune Diabetes in Adult (LADA) type ...
Read More
Source: PubMed
BMJ Case Rep
Spontaneous extensive pneumocephalous as a rare manifestation of Escherichia coli suppurative meningitis in Diabetic ketoacidosis.
Dhir A, Dahiya S, Bhardwaj N, Gupta M
Read More
Source: PubMed
